Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased atherosclerotic lesion formation and vascular leukocyte accumulation in renal impairment are mediated by interleukin-17A.

Circulation research - 27 Sept 2013

Ge Shuwang, Hertel Barbara, Koltsova Ekaterina K, Sörensen-Zender Inga, Kielstein Jan T, Ley Klaus, Haller Hermann, von Vietinghoff Sibylle

Abstract excerpt

RATIONALE: Atherosclerosis is a major cause of death in patients with chronic kidney disease. Chronic inflammation of the arterial wall including invasion, proliferation, and differentiation of leukocytes is important in atherosclerotic lesion development. How atherosclerotic inflammation is alte...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aorta
Share to CD11c Antigen
Share to Glomerular Filtration Rate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interleukin-17

Share to Kidney Diseases

Share to Lipoproteins, LDL

Share to Plaque, Atherosclerotic

Share to Receptors, LDL

Source

Open in PubMed Open full text

Identifiers

PMID: 23908345
DOI: 10.1161/CIRCRESAHA.113.301934
PMCID: PMC3848055

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23908345-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increased atherosclerotic lesion formation and vascular leukocyte accumulation in renal impairment are mediated by interleukin-17A.PMID 23908345Read ↗

IL-17A Influences Essential Functions of the Monocyte/Macrophage Lineage and Is Involved in Advanced Murine and Human AtherosclerosisSemantic proximity Read ↗

Inflammation in end-stage renal disease--what have we learned in 10 years?Semantic proximity Read ↗

Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.Semantic proximity Read ↗

Current views on the functions of interleukin-17A-producing cells in atherosclerosisSemantic proximity Read ↗

Atherosclerosis following renal injury is ameliorated by pioglitazone and losartan via macrophage phenotype.Semantic proximity Read ↗

A major role for RCAN1 in atherosclerosis progression.Semantic proximity Read ↗

Prevention of accelerated atherosclerosis by AT1 receptor blockade in experimental renal failure.Semantic proximity Read ↗

Inflammation, Senescence and MicroRNAs in Chronic Kidney DiseaseSemantic proximity Read ↗

ApoL1 renal risk variants induce aberrant THP-1 monocyte differentiation and increase eicosanoid production via enhanced expression of cyclooxygenase-2.Semantic proximity Read ↗

IL-27 receptor-regulated stress myelopoiesis drives abdominal aortic aneurysm developmentSemantic proximity Read ↗

The pleiotropic role of interleukin-17 in atherosclerosis.Semantic proximity Read ↗

IL-27 receptor signaling regulated stress myelopoiesis drives Abdominal Aortic Aneurysm developmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.